Previous close | 8.13 |
Open | 7.93 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 7.90 - 8.19 |
52-week range | 5.01 - 10.75 |
Volume | |
Avg. volume | 218,134 |
Market cap | 10.145M |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | 65.83 |
EPS (TTM) | 0.12 |
Earnings date | 13 May 2024 - 17 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 40.00 |
While Guardion Health Sciences, Inc. ( NASDAQ:GHSI ) might not have the largest market cap around , it saw a...
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary, which owns the Viactiv® brand and business, to Doctor’s Best Inc. (“Doctor’s Best”), a wholly-owned subsidiary of Kingdomway USA Corp. (“Kingdomway”), for gross cash consideration of $17.2 million, payable in full at closing. The transaction has been approved by